id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0247-0002,FDA,FDA-2004-D-0247,GUIDANCE,Supporting & Related Material,GDL-Guidance,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:35:26Z,,0,0,0900006480471afc
FDA-2004-D-0247-0003,FDA,FDA-2004-D-0247,GUIDANCE,Supporting & Related Material,GDL-Guidance,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:35:26Z,,0,0,0900006480471afd
FDA-2004-D-0247-0004,FDA,FDA-2004-D-0247,GUIDANCE,Supporting & Related Material,GDL-Guidance,2004-12-21T05:00:00Z,2004,12,,,2008-04-12T00:35:26Z,,0,0,0900006480471afe
FDA-2004-D-0247-0001,FDA,FDA-2004-D-0247,FDA,Notice,NAD-Notice of Availability of Data,2004-12-21T05:00:00Z,2004,12,2004-12-10T05:00:00Z,2005-12-13T04:59:59Z,2008-04-12T00:35:26Z,,0,0,0900006480471af9